Hi, In the latest address to the shareholders, it is mentioned of late stage negotiations of potential US partners for release into USA, hopefully a good ann' on that will resume interest in HTX. Oct 2009, $2.7M funding from Springtree NY, has that been fully utilised yet?, any idea when this arrangement will cease? Parts 1 & 2 of stage 2 trials have been studied, am I correct in understanding that? with 86.1% correctly identified, was looking for over 90%?(but still better than CA125), what now? From memory we were expecting ann' this Nov', but I think it was the results from Part 2 of studies, but cant find that ann' now.
cheers
HTX Price at posting:
1.5¢ Sentiment: Hold Disclosure: Held
